Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8306)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2014 (publication date) through Jul 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Thong VD, Akkarathamrongsin S, Poovorawan K, Tangkijvanich P, Poovorawan Y. Hepatitis C virus genotype 6: Virology, epidemiology, genetic variation and clinical implication. World J Gastroenterol 2014; 20(11): 2927-2940 [PMID: 24659883 DOI: 10.3748/wjg.v20.i11.2927] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i11/2927.htm |
| Number | Citing Articles |
| 1 |
V. O. Kotova, L. A. Balakhontseva, E. A. Bazykina, O. E. Trotsenko, V. N. Beldy, S. E. Kirdyashova. Genetic diversity of hepatitis C virus in Nanaian region, Khabarovsk territory. Russian Journal of Infection and Immunity 2021; 11(1): 148 doi: 10.15789/2220-7619-GDO-1265
|
| 2 |
Charlotte Pronier, Hélène Fontaine, Céline Dorival, Fabrice Carrat, Stanislas Pol, Vincent Thibault. Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategy. Journal of Viral Hepatitis 2019; 26(11): 1276 doi: 10.1111/jvh.13171
|
| 3 |
Yu‐Ping Chang, Chiuan‐Bo Huang, Tung‐Hung Su, Chun‐Jen Liu, Tai‐Chung Tseng, Shang‐Chin Huang, Pei‐Jer Chen, Jia‐Horng Kao, Chen‐Hua Liu. Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping. Journal of Medical Virology 2024; 96(5) doi: 10.1002/jmv.29686
|
| 4 |
Chun-Han Cheng, Ching-Chung Lin, Huan-Lin Chen, I-Tsung Lin, Chia-Hsien Wu, Yuan-Kai Lee, Ming-Jong Bair, Chen-Hua Liu. Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection. PLOS ONE 2018; 13(2): e0191799 doi: 10.1371/journal.pone.0191799
|
| 5 |
Simona Ruta, Costin Cernescu. Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes. World Journal of Gastroenterology 2015; 21(38): 10811-10823 doi: 10.3748/wjg.v21.i38.10811
|
| 6 |
Guan-Jhou Chen, Hsin-Yun Sun, Sui-Yuan Chang, Li-Hsin Su, Yi-Ting Chen, Szu-Min Hsieh, Wan-Da Liu, Wang-Huei Sheng, Yu-Shan Huang, Kuan-Yin Lin, Yi-Ching Su, Wen-Chun Liu, Chien-Ching Hung. Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: the emerging role of genotype 6. Emerging Microbes & Infections 2022; 11(1): 1227 doi: 10.1080/22221751.2022.2065933
|
| 7 |
C. L. Lai, V. W.‐S. Wong, M. F. Yuen, J. C. Yang, S. J. Knox, H. Mo, L. L. Han, D. M. Brainard, H. L. Y. Chan. Sofosbuvir plus ribavirin for the treatment of patients with chronic genotype 1 or 6 hepatitis C virus infection in Hong Kong. Alimentary Pharmacology & Therapeutics 2016; 43(1): 96 doi: 10.1111/apt.13429
|
| 8 |
Ekta Gupta, Jasmine Samal, Amit Pandey, Gaurav Singh, Hajra A. S. Gupta, Reshu Agarwal, Manoj Kumar Sharma. Treatment Response and Drug Resistance Profiling of Genotype 6 of Hepatitis C Virus in HCV/HIV Co-Infected Patients: A Pilot Study from INDIA. Viruses 2022; 14(5): 944 doi: 10.3390/v14050944
|
| 9 |
Jyh-Jou Chen, Hung-Da Tung, Pei-Lun Lee, Hsing-Tao Kuo, Ming-Jen Sheu, Chun-Ta Cheng, Tang-Wei Chuang, Hsu-Ju Kao, Na-Mi Lu, Li-Ching Wu, Chuan Lee. High prevalence of genotype 6 hepatitis C virus infection in Southern Taiwan using Abbott genotype assays. Journal of the Formosan Medical Association 2020; 119(1): 413 doi: 10.1016/j.jfma.2019.07.021
|
| 10 |
Y.-Q. Tong, B. Liu, H. Liu, H.-Y. Zheng, J. Gu, H. Liu, E.J. Song, C. Song, Y. Li. Accurate genotyping of hepatitis C virus through nucleotide sequencing and identification of new HCV subtypes in China population. Clinical Microbiology and Infection 2015; 21(9): 874.e9 doi: 10.1016/j.cmi.2015.05.034
|
| 11 |
Vo Duy Thong, Kittiyod Poovorawan, Pisit Tangkijvanich, Rujipat Wasitthankasem, Sompong Vongpunsawad, Yong Poovorawan. Influence of Host and Viral Factors on Patients with Chronic Hepatitis C Virus Genotype 6 Treated with Pegylated Interferon and Ribavirin: A Systematic Review and Meta-Analysis. Intervirology 2015; 58(6): 373 doi: 10.1159/000444366
|
| 12 |
Dong‐Bo Wu, Wei Jiang, Yong‐Hong Wang, Bin Chen, Meng‐Lan Wang, Ya‐Chao Tao, En‐Qiang Chen, Hong Tang. Safety and efficacy of sofosbuvir‐based direct‐acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real‐world experience of a retrospective study. Journal of Viral Hepatitis 2019; 26(3): 316 doi: 10.1111/jvh.13033
|
| 13 |
Desmond Y. H. Yap, Kevin S. H. Liu, Yu-Chun Hsu, Grace L. H. Wong, Ming-Chang Tsai, Chien-Hung Chen, Ching-Sheng Hsu, Yee Tak Hui, Michael K. K. Li, Chen-Hua Liu, Yee-Man Kan, Ming-Lung Yu, Man-Fung Yuen. Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment. Clinical and Molecular Hepatology 2020; 26(4): 554 doi: 10.3350/cmh.2020.0058
|
| 14 |
Ru Xu, Hao Wang, Jieting Huang, Min Wang, Qiao Liao, Zhengang Shan, Huishan Zhong, Xia Rong, Yongshui Fu. Complete genome sequencing and evolutionary analysis of hepatitis C virus subtype 6a, including strains from Guangdong Province, China. Archives of Virology 2022; 167(2): 591 doi: 10.1007/s00705-021-05358-7
|
| 15 |
Chin-Wen Hsu, Wan-Wen Yang, Chia-Yi Hou, I-Jung Feng, Ting-Yi Huang, Pei-Lun Lee, How-Ran Guo, Chien-Yuan Huang, Shih-Bin Su. Patients with Hepatitis C Undergoing Direct-Acting Antiviral Treatment Have a Lower SARS-CoV-2 Infection Rate. Life 2023; 13(12): 2326 doi: 10.3390/life13122326
|
| 16 |
Edward J. Gane, Robert H. Hyland, Di An, Evguenia Svarovskaia, Phillip S. Pang, Diana Brainard, Catherine A. Stedman. Efficacy of Ledipasvir and Sofosbuvir, With or Without Ribavirin, for 12 Weeks in Patients With HCV Genotype 3 or 6 Infection. Gastroenterology 2015; 149(6): 1454 doi: 10.1053/j.gastro.2015.07.063
|
| 17 |
Hung-Da Tung, Pei-Lun Lee, Jyh-Jou Chen, Hsing-Tao Kuo, Ming-Jen Sheu, Chun-Ta Cheng, Tang-Wei Chuang, Hsu-Ju Kao, Yu-Hsun Wu, Mai-Gio Pang, Cheng-Heng Lin, Chia-Yi Hou, Hsin-Hua Tsai, Li-Ching Wu, Chuan Lee. Hepatitis C Virus Subtypes Novel 6g-Related Subtype and 6w Could Be Indigenous in Southern Taiwan with Characteristic Geographic Distribution. Viruses 2021; 13(7): 1316 doi: 10.3390/v13071316
|
| 18 |
Bhupen Barman, Kaustubh Bora, Kryshanlang G. Lynrah, W. Valarie Lyngdoh, Mohammad Jamil. Hepatitis C Virus and its Genotypes in Chronic Liver Disease Patients from Meghalaya, Northeast India. Indian Journal of Medical Microbiology 2018; 36(3): 376 doi: 10.4103/ijmm.IJMM_17_371
|
| 19 |
Parisa Ebrahimzadeh, Mohammadreza Haghshenas, Farhang Babamahmoodi. The Prevalence of Hepatitis C Virus Genotypes in Mazandaran Province, Iran. Jundishapur Journal of Microbiology 2017; (In press) doi: 10.5812/jjm.40750
|
| 20 |
Winifred Nyinoh Iveren. Genotypic variation, demographic characteristics and risk factors of hepatitis C virus in Scotland. Journal of Public Health and Epidemiology 2018; 10(7): 241 doi: 10.5897/JPHE2018.1031
|
| 21 |
Hung-Da Tung, Jyh-Jou Chen. Genetic history of hepatitis C virus genotype 6 in Taiwan. Journal of the Formosan Medical Association 2023; doi: 10.1016/j.jfma.2023.10.013
|
| 22 |
Maria Corina Plaz Torres, Alessio Aghemo. Editorial: should we abandon HCV genotype testing? Maybe. Alimentary Pharmacology & Therapeutics 2019; 49(8): 1097 doi: 10.1111/apt.15194
|
| 23 |
E. A. Leybman, L. I. Nikolaeva, E. I. Samokhvalov, K. K. Kyuregayn, O. V. Isaeva, G. V. Sapronov, T. V. Cherednechenko, A. G. Pisarev, A. E. Grishechkin, M. I. Michailov, V. F. Uchaikin. Peculiarity of Clinical Course of Childhood Hepatitis C Depending on the Viral Genotype. Epidemiology and Vaccine Prevention 2015; 14(1): 49 doi: 10.31631/2073-3046-2015-14-1-49-55
|
| 24 |
Dagmara Szkolnicka, Baltasar Lucendo-Villarin, Joanna K. Moore, Kenneth J. Simpson, Stuart J. Forbes, David C. Hay. Reducing Hepatocyte Injury and Necrosis in Response to Paracetamol Using Noncoding RNAs. Stem Cells Translational Medicine 2016; 5(6): 764 doi: 10.5966/sctm.2015-0117
|
| 25 |
Cheng-Pin Chen, Chien-Yu Cheng, Huachun Zou, Chun-Han Cheng, Shu-Hsing Cheng, Cheng-Kuo Chen, Ching-Hsiang Chen, Ming-Jong Bair. Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings. Journal of Microbiology, Immunology and Infection 2019; 52(4): 556 doi: 10.1016/j.jmii.2018.10.002
|
| 26 |
Amira Souii, Aida Elargoubi, Catherine Fallecker, Maha Mastouri, Emmanuel Drouet. Hepatitis C Genotype Prevalence in Monastir Region, Tunisia: Correlation between 5′ Untranslated Region (5′UTR), Non-structural 5B (NS5B), and Core Sequences in HCV Subtyping. Current Microbiology 2016; 73(3): 324 doi: 10.1007/s00284-016-1064-2
|
| 27 |
Su Rin Shin, Young Seok Kim, Young-Seok Lim, June Sung Lee, Jin Woo Lee, Sun Myung Kim, Sook-Hyang Jeong, Joo Hyun Sohn, Myung Seok Lee, Sang Hoon Park. Clinical Characteristics and Treatment Outcome of Peginterferon Plus Ribavirin in Patients Infected with Genotype 6 Hepatitis C Virus in Korea: A Multicenter Study. Gut and Liver 2017; 11(2): 270 doi: 10.5009/gnl16163
|
| 28 |
Gretja Schnell, Preethi Krishnan, Rakesh Tripathi, Jill Beyer, Thomas Reisch, Michelle Irvin, Tatyana Dekhtyar, Liangjun Lu, Teresa I. Ng, Wangang Xie, Tami Pilot-Matias, Christine Collins, Jason Blackard. Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir. PLOS ONE 2018; 13(10): e0205186 doi: 10.1371/journal.pone.0205186
|
| 29 |
Nur Amalin Zahirah Mohd Amin, Tuan Nur Akmalina Mat Jusoh, Ahmad Adebayo Irekeola, Rafidah Hanim Shueb. Hepatitis C: A Review on Current and Emerging Genotyping Assays. Malaysian Journal of Medicine and Health Sciences 2023; 19(5): 359 doi: 10.47836/mjmhs.19.5.41
|
| 30 |
Tarik Asselah, Tarek Hassanein, Imam Waked, Abdellah Mansouri, Geoffrey Dusheiko, Edward Gane. Eliminating hepatitis C within low-income countries – The need to cure genotypes 4, 5, 6. Journal of Hepatology 2018; 68(4): 814 doi: 10.1016/j.jhep.2017.11.037
|
| 31 |
Yuan‐Chih Mao, I‐I Chen, Lein‐Ray Mo. Direct‐acting antiviral therapy for chronic hepatitis C among incarcerated people who inject drugs. Advances in Digestive Medicine 2023; 10(3): 171 doi: 10.1002/aid2.13338
|
| 32 |
Vo Duy Thong, Srunthron Akkarathamrongsin, Anchalee Avihingsanon, Apiradee Theamboonlers, Yong Poovorawan, Pisit Tangkijvanich. The Correlation between Hepatitis C Core Antigen and Hepatitis C Virus RNA Levels with Respect to Human Immunodeficiency Virus Status, Hepatitis C Virus Genotype and Interferon-Lambda-4 Polymorphism. Intervirology 2015; 58(2): 73 doi: 10.1159/000370070
|
| 33 |
Hung-Da Tung, Pei-Lun Lee, Jyh-Jou Chen, Hsing-Tao Kuo, Ming-Jen Sheu, Chun-Ta Cheng, Tang-Wei Chuang, Hsu-Ju Kao, Chia-Yi Hou, Hsin-Hua Tsai, Li-Ching Wu, Chuan Lee. Geographic variation of genotype 6 hepatitis C virus infection in an endemic area of southern Taiwan. Journal of the Formosan Medical Association 2020; 119(12): 1876 doi: 10.1016/j.jfma.2020.06.001
|
| 34 |
RoccoLuca Emanuele Liardo, AntonioMaria Borzì, Corrado Spatola, Barbara Martino, Giuseppe Privitera, Francesco Basile, Antonio Biondi, Marco Vacante. Effects of infections on the pathogenesis of cancer. Indian Journal of Medical Research 2021; 153(4): 431 doi: 10.4103/ijmr.IJMR_339_19
|
| 35 |
|
| 36 |
Maggie Phillips, Jumana Abboud, Bukola Abodunde, David P. Paul, Alberto Coustasse. The Growing Problem of Hepatitis C Virus Infection. The Health Care Manager 2020; 39(1): 2 doi: 10.1097/HCM.0000000000000278
|
| 37 |
Zhonglan Wu, Lijia Cui, Weiming Zhao, Dongzhi Yang, Hui Chen, Ruiqing Wang, Xuemin Wang, Linqi Zhang, Tianhua He. Molecular epidemiology of hepatitis C infections in Ningxia, China: genotype, phylogeny and mutation analysis. Virology Journal 2016; 13(1) doi: 10.1186/s12985-016-0635-y
|
| 38 |
Ru Xu, Elihu Aranday-Cortes, E Carol McWilliam Leitch, Joseph Hughes, Joshua B Singer, Vattipally Sreenu, Lily Tong, Ana da Silva Filipe, Connor G G Bamford, Xia Rong, Jieting Huang, Min Wang, Yongshui Fu, John McLauchlan. The evolutionary dynamics and epidemiological history of hepatitis C virus genotype 6, including unique strains from the Li community of Hainan Island, China. Virus Evolution 2022; 8(1) doi: 10.1093/ve/veac012
|
| 39 |
Mei Ye, Xin Chen, Yu Wang, Lin Duo, Chiyu Zhang, Yong-Tang Zheng. Identification of a New HCV Subtype 6xg Among Injection Drug Users in Kachin, Myanmar. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.00814
|
| 40 |
Zhenzhou Wan, Qianqian Chen, Xin Chen, Lin Duo, Peilu Li, Yong-Tang Zheng, Chiyu Zhang, Zhefeng Meng. HCV Diversity among Chinese and Burmese IDUs in Dehong, Yunnan, China. PLOS ONE 2016; 11(9): e0163062 doi: 10.1371/journal.pone.0163062
|
| 41 |
Manish Dwivedi, Aditya Dwivedi, Debalina Mukherjee. An Insight into Hepatitis C Virus: In Search of Promising Drug Targets. Current Drug Targets 2023; 24(14): 1127 doi: 10.2174/0113894501265769231020031857
|
| 42 |
Kittiyod Poovorawan, Sombat Treeprasertsuk, Kaewjai Thepsuthammarat, Polrat Wilairatana, Bubpha Kitsahawong, Kamthorn Phaosawasdi. The burden of cirrhosis and impact of universal coverage public health care system in Thailand: Nationwide study. Annals of Hepatology 2015; 14(6): 862 doi: 10.5604/16652681.1171773
|
| 43 |
Tarik Asselah, Samuel S Lee, Betty B Yao, Tuan Nguyen, Florence Wong, Adam Mahomed, Seng Gee Lim, Armand Abergel, Joe Sasadeusz, Edward Gane, Neddie Zadeikis, Gretja Schnell, Zhenzhen Zhang, Ariel Porcalla, Federico J Mensa, Kinh Nguyen. Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial. The Lancet Gastroenterology & Hepatology 2019; 4(1): 45 doi: 10.1016/S2468-1253(18)30341-8
|
| 44 |
Chun‐Han Cheng, Huan‐Lin Chen, I‐Tsung Lin, Chia‐Hsien Wu, Yuan‐Kai Lee, Ming‐Wun Wong, Ming‐Jong Bair. The genotype distribution of hepatitis C in southeastern Taiwan: Clinical characteristics, racial difference, and therapeutic response. The Kaohsiung Journal of Medical Sciences 2015; 31(11): 597 doi: 10.1016/j.kjms.2015.09.006
|
| 45 |
Ghirmay Ghebrekidan Ghebremeskel, Michael Berhe Solomon, Oliver Okoth Achila, Samuel Tekle Mengistu, Rahel Frezghi Asmelash, Araia Berhane Mesfin, Mohammed Elfatih Hamida. Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in Eritrea. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47258-7
|